Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011–2022) | Annals of Internal Medicine
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? View all available purchase options and get full access to this article. Author Disclosures (annals-24-00614_supplement-disclosureforms.pdf) Wouters OJ, Naci H, Papanicolas I. Availability and coverage of new drugs in 6 high-income countries with health technology assessment bodies. JAMA Intern Med. 2024;184:328-330.
